Maynard Um
-
-
-
-
-
-
-
Dr. Reddys Labs (RDY) Reports Q4 EPS of Rs14.52
-
-
-
-
-
-
-
Dr. Reddy's (RDY) stock rises on biosimilar collaboration with Alvotech (ALVO)
-
-
-
-
-
-
-
Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Raised to INR1,620 at BofA Securities
-
-
-
-
-
-
-
Dr. Reddys Labs (RDY) Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
-
-
-
-
415,791 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

